RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: acute promyelocytic leukemia
Accession: DOID:0060318
browse the term
Definition: An acute myeloid leukemia characterized by accumulation of promyelocytes in the bone marrow and by a translocation between chromosomes 15 and 17. (DO)
Synonyms: exact_synonym: AML M3; APL; M3 ANLL; acute myeloblastic leukaemia type 3; acute myeloblastic leukemia type 3; acute myeloid leukaemia M3; acute myeloid leukemia, M3; acute promyelocytic leukaemia; acute promyelocytic leukemias; progranulocytic leukemia
related_synonym: DNA TOPOISOMERASE II, RESISTANCE TO INHIBITION OF, BY AMSACRINE
primary_id: MESH:D015473
alt_id: OMIM:612376
xref: EFO:0000224 ; GARD:538 ; ICD10CM:C92.4 ; NCI:C3182 ; ORDO:520
G
Abca1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cebpa
CCAAT/enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpe
CCAAT/enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
G
Dapk2
death-associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr 8:66,706,536...66,825,567
Ensembl chr 8:66,706,609...66,825,567
G
Defa11
defensin alpha 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16019513
NCBI chr16:70,533,436...70,535,592
Ensembl chr16:70,533,436...70,535,604
G
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16206674 PMID:10726043
RGD:11340216
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
G
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
RGD
PMID:21875282
RGD:10755406
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Kmt2e
lysine methyltransferase 2E
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373
G
Lat2
linker for activation of T cells family, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
G
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr13:96,362,810...96,397,284
G
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853 PMID:21059853
RGD:11532756 , RGD:11532756
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14508522 PMID:26285909 PMID:15659732
RGD:1600902
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:25741868 PMID:28492532
NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:156,326,259...156,372,855
G
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Pml
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 PMID:9122233 More...
RGD:41404695
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Pramex1
PRAME like, X-linked 1
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr X:98,567,994...98,574,654
Ensembl chr X:98,569,415...98,572,096
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Rap1gap
Rap1 GTPase-activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rara
retinoic acid receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD RGD
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:17712046 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21613260 PMID:22213200 PMID:23208507 PMID:25583766 PMID:26285909 PMID:26728337 PMID:28314734 PMID:32882258 PMID:32929351 PMID:15659732 More...
RGD:1600902
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
G
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 3:114,466,095...114,478,894
Ensembl chr 3:114,466,171...114,477,519
G
Top2a
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23208507 PMID:8387545
RGD:1599922
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all